Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.51 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.51 |
| ▸ | CTSL | P07711 | 1/20 | 0.51 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.51 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.50 |
| ▸ | ANPEP | P15144 | 1/20 | 0.49 |
| ▸ | DPP4 | P27487 | 2/20 | 0.48 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.48 |
| ▸ | CPB1 | P15086 | 1/20 | 0.47 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26212052 | 0.96 | DPP8 (0.49) | DPP8DPP7CTSLSIRT2FOLH1 | |
| SCHEMBL31679028 | 0.91 | DPP8 (0.49) | DPP8DPP7CTSLSIRT2FOLH1 | |
| SCHEMBL31679020 | 0.91 | CTSL (0.53) | CTSLPTGER4 | |
| SCHEMBL22117406 | 0.90 | SIRT2 (0.50) | DPP8DPP7CTSLSIRT2FOLH1 | |
| SCHEMBL22117407 | 0.90 | SIRT2 (0.50) | DPP8DPP7CTSLSIRT2FOLH1 | |
| SCHEMBL31679017 | 0.87 | CTSL (0.49) | CTSLSIRT2PTGER4 | |
| SCHEMBL17073781 | 0.85 | CTSL (0.63) | DPP8DPP7CTSLSIRT2FOLH1 | |
| SCHEMBL31679027 | 0.83 | KMT2A (0.48) | CTSLSIRT2FOLH1 | |
| SCHEMBL30341837 | 0.83 | KLK7 (0.54) | CTSLSIRT2 | |
| SCHEMBL22117557 | 0.82 | CTSL (0.51) | CTSLSIRT2PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12404300-B2 | Mitochondria-targeting peptides | STEALTH BIOTHERAPEUTICS INC. (US) | 2025-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12404300-B2 | Mitochondria-targeting peptides | SSBP1, HSPE1, IMMT | DPP8 1568/4885DPP7 1306/4885CTSL 1491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.